Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HS Light Drop is a medical cannabis flower product line developed and distributed by DEMECAN. It is available in various cultivars, such as 'Rainbow Dawg' (with approximately 18% THC and <1% CBD) and 'Santa Maria Golden x C99' (with approximately 17% THC and <1% CBD). These unirradiated (unbestrahlt) hybrid cannabis flowers are prescribed for therapeutic purposes, including the management of depression, stress, spasms, and appetite loss. The active phytocannabinoids, primarily tetrahydrocannabinol (THC) and cannabidiol (CBD), exert their therapeutic effects by interacting with the endocannabinoid system, specifically targeting cannabinoid receptors CB1 and CB2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on HS Light Drop.